Regenerating Bone.

Restoring Possibilities.

We’re Not Done Yet

Our campaign exceeded expectations and reached its original cap. We’re now expanding the raise to $1.235M to fuel the next phase of innovation.
There’s still time to join.

Lifetime Raised

$ 0

Investors

Transforming Bone Health with Precision Regenerative Solutions

At OsNovum, we are pioneering a precision approach to develop regenerative therapies designed to transform the lives of patients with osteoporotic conditions.

While there are many drugs available on the market for osteoporosis treatment, they frequently cause significant side effects and patients often refuse treatment to avoid those adverse systemic effects.

FDA-Cleared Innovation Poised to Transform Skeletal Health

Our technology has actually been FDA-cleared and successfully regenerating maxillofacial bone for years across the country.

Developed by the pioneers at SteinerBio, this innovative regenerative material transforms weak, poorly mineralized bone into healthy vital bone.

We believe it’s time to take this breakthrough material to the skeleton.

Our material is designed to deliver targeted, localized treatment to weakened areas of skeletal bone before they fracture.

The result?

A revolutionary approach to osteoporosis that restores

strength and resilience to bones without systemic side effects.

Under the Microscope

Our innovative patented molecule activates the body’s own bone-building cells (osteoblasts), transforming weak bone into strong, healthy tissue:

◊ Absorption: Osteoblasts absorb our patented molecule at the site of weakened bone

◊ Activation: A biological response is triggered, stimulating rapid new bone formation

◊ Regeneration: The treated bone increases in density and vitality, preventing fracture

The High Cost of Osteoporosis:

Lives & Dollars

Osteoporosis leaves millions with no safe, effective treatment options.

Patients face a choice between medications with severe side effects or no treatment at all.

With the economic burden of osteoporosis projected to exceed $25 billion annually, the demand for a better solution has never been greater.

OsNovum is ready to answer the call.

Osteoporosis by the Numbers

Up to 80% of osteoporosis patients go untreated due to fear of severe side effects.

Fractures will already devastate a patient’s quality of life, but the crushing anxiety that comes with worrying about a fracture is an immeasurable burden that doesn’t get counted in the statistics.

Transforming Skeletal Health with Regenerative Innovation

OsNovum is not just pioneering a breakthrough treatment—it’s introducing an entirely new standard of care for osteoporosis.

Our approach goes beyond conventional drug therapies by regenerating bone at the source, ensuring long-term skeletal health without systemic side effects.

Typically, a patient’s physician has minimal training in treating osteoporosis. Most physicians simply make a diagnosis and prescribe a drug. We are going to revolutionize this model with the introduction of OsNovum facilities designed exclusively for the treatment of skeletal diseases.

Building the Future of Skeletal Care

By integrating cutting-edge biotechnology with specialized care facilities, OsNovum is poised to disrupt the osteoporosis treatment market. We’re backed by believers. Now we’re building for patients. This is the future of skeletal health.

Strategic Vision for OsNovum Clinics

Our facilities will be a direct conduit of new scientific knowledge from the scientist to the patient. OsNovum will contract with top leading scientists from the various fields to formulate our diagnostics and treatment protocols.

Medical Expertise & Collaboration: We are building the foundation for an entirely new approach to osteoporosis treatment by partnering with top scientists, clinicians, and leaders from various fields to formulate our diagnostics and treatment protocols.

Scalability & Expansion: Initial rollout in select facilities will pave the way for nationwide adoption, offering patients a revolutionary alternative to traditional osteoporosis treatments.

Localized Application, Global Impact: Our proprietary regenerative material will be applied in clinical settings, restoring bone health and preventing fractures before they happen.

Want to support the journey?

We’re pushing forward. Join us.

We raised over $350,000 through Wefunder, thanks to a community of believers who share our mission to transform skeletal health.

Early supporters of OsNovum helped us exceed our original investment cap. Now, we’re extending our raise to $1.235 million so we can advance our FDA submission, scale R&D, and deliver this groundbreaking solution to those who need it most.

The opportunity is still open. The mission is more urgent than ever.

Help us build the future of bone regeneration:

Stay Connected

Subscribe to our periodic updates so you can stay informed on the latest news regarding OsNovum’s funding efforts, company milestones, and new innovations.

Early investors saw the potential. Here’s what resonated.

These messages came from the first wave of investors who helped bring OsNovum to life. Many of them patients, caregivers, and visionaries who recognized the urgency and potential of our mission:

PROUD MEMBER OF:

Tissue Engineering and Regenerative Medicine International Society (TERMIS)
American Society for Bone and Mineral Research (ASBMR)